Clinical Trials List
2020-03-17 - 2024-05-02
Phase III
Terminated8
-
Trial Applicant
BAYER TAIWAN COMPANY LTD.
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- WEI-WEN LIN 無
- 王奇彥 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wen-Chung Yu 無
- 黃少嵩 無
- Kang-Ling Wang 無
- Hao-min Cheng 無
- Tse-Min Lu 無
- Shih-Hsien Sung 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Kuang-Hsing Chiang 無
- Wei-Fung Bi 無
- Yung-Ta Kao 無
- 陳志維 無
- Tsung-Lin Yang 無
- 蕭卜源 無
- Chun-Ming Shih 無
- Chien-Yi Hsu 無
- 蕭成儀 無
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 吳韋璁 無
- Chun-Yuan Chu 無
- Po-Chao Hsu 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 黃惠君 無
- 洪啟盛 無
- HUNG-JU LIN 無
- LIAN-YU LIN 無
- 林柏志 無
- 賀立婷 無
- 陳盈憲 無
- 張博淵 無
- JEN-KUANG LEE 無
- WEN-JONE CHEN 無
- 黃慶昌 無
- CHO-KAI WU 無
- 江君揚 無
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
116 participants
-
Global
6900 participants
